Jennifer L Moseley

Analysis of Sprinkler use in a Library Stack Room Using Fire Dynamics Simulator

Ryan S LaFalam, Jennifer L Moseley, Ryan Thomann, 2008 .

Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study

Jennifer L Moseley, G. Nuovo, M. Coffey, 2019, Clinical Cancer Research.

A study of pelareorep in combination with pembrolizumab and chemotherapy in patients (pts) with relapsed metastatic adenocarcinoma of the pancreas (MAP).

Jennifer L Moseley, G. Nuovo, D. Mahalingam, 2017 .

Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies

Jennifer L Moseley, L. Chirieac, G. Shapiro, 2017, British Journal of Cancer.

A phase I dose-escalation study of the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of the novel cyclin-dependent kinase inhibitor SCH 727965 administered every 3 weeks in subjects with advanced malignancies

Jennifer L Moseley, G. Shapiro, C. Takimoto, 2008 .

First in human phase I study of BSI-201, a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in subjects with advanced solid tumors

Jennifer L Moseley, A. Tolcher, S. Kopetz, 2008 .

A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma

Jennifer L Moseley, M. Coffey, B. Thompson, 2017, Cancer Chemotherapy and Pharmacology.

Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors

Jennifer L Moseley, A. Lockhart, M. Mita, 2014, Investigational New Drugs.